Importantly, the combination of functional data obtained by saturating mutagenesis with mutational probabilities derived from the most common mutagenic processes in cancer provided a near-perfect model of the observed spectrum of TP53 missense variants, without the need to postulate additional oncogenic gain-of-function effects [40]. The gene discussed is TP53; the disease is cancer.